Natco Pharma (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Natco Pharma" in English language version.

refsWebsite

Global rank English rank

4natcopharma.co.in

low place

low place

2thehindubusinessline.com

724^th place

431^st place

390^th place

227^th place

1forbesindia.com

1,886^th place

990^th place

1moneycontrol.com

1,437^th place

778^th place

1indiatimes.com

17^th place

15^th place

low place

low place

1businesstoday.in

1,332^nd place

708^th place

1thepharmaletter.com

low place

low place

1dailyexcelsior.com

9,968^th place

5,811^th place

angelone.in

Akolkar, Shrikant (9 March 2017). "Natco Pharma: Top league player" (PDF). Angel One. Retrieved 25 April 2022.

businesstoday.in

"Niche Play". Business Today. Retrieved 19 April 2020.

dailyexcelsior.com

"Natco Pharma to invest Rs 100 cr for setting up agrichemical facilities in Andhra". 25 January 2019.

forbesindia.com

"Natco Pharma: In fine fettle". Forbes India. Retrieved 19 April 2020.

indiatimes.com

economictimes.indiatimes.com

PTI (17 December 2020). "Natco Pharma launches anti blood clot medication, Rivaroxaban, in India". The Economic Times. Retrieved 25 April 2022.

livemint.com

"Facing headwinds in US, Natco Pharma looks to scale up business in China". Livemint. Retrieved 19 April 2020.

moneycontrol.com

"How Natco defied the odds to rise up India's pharma ladder". Moneycontrol. Retrieved 19 April 2020.

natcopharma.co.in

https://www.natcopharma.co.in/wp-content/uploads/2024/05/Q4EarningsPresentation2024.pdf ^{[bare URL PDF]}
https://www.natcopharma.co.in/wp-content/uploads/2024/05/Q4EarningsPresentation2024.pdf ^{[bare URL PDF]}
"Our Business | Natco Pharma". Retrieved 25 April 2022.
"Mission & Heritage | Natco Pharma". Retrieved 25 April 2022.

thehindubusinessline.com

"Natco Pharma lines up 20 'Para IV' products". The Hindu Business Line. Retrieved 19 April 2020.
Sridhar, G. Naga (25 November 2020). "Natco Pharma expects agri business to be key growth lever". www.thehindubusinessline.com. Retrieved 24 April 2022.

thepharmaletter.com

"Bayer cancer drug faces new Nexavar patent problems in India". www.thepharmaletter.com. Retrieved 3 February 2022.